CIA
RCEL icon

Cape Investment Advisory’s Avita Medical RCEL Stock Holding History

Cape Investment Advisory’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-213
Closed -$2.92K – 1124
2023
Q4 		$2.92K Buy
+213
New +$2.44K ﹤0.01% 873

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Cape Investment Advisory's RCEL Position: Q1 2024 in Review

Cape Investment Advisory sold out of Avita Medical (RCEL) in Q1 2024, closing a stake of 213 shares — an estimated $2.92K sold.

Cape Investment Advisory first reported a position in RCEL in Q4 2023 and held it in 1 quarter. The position peaked at $2.92K in Q4 2023. 82 funds tracked by Wall St. Rank hold RCEL as of Q1 2024.

  • Cape Investment Advisory reported no remaining Avita Medical position as of Q1 2024 after selling out during the quarter.
  • Cape Investment Advisory sold 213 Avita Medical shares in Q1 2024, an estimated $2.92K.
  • Cape Investment Advisory first reported a position in Avita Medical in Q4 2023 and held it in 1 quarter.
  • Cape Investment Advisory's Avita Medical position peaked at $2.92K in Q4 2023.
  • 82 funds tracked by Wall St. Rank held Avita Medical as of Q1 2024.

Based on Cape Investment Advisory's 13F filing for Q1 2024, filed 21 Jun 2024.